631 related articles for article (PubMed ID: 26735015)
1. FOXO1 couples metabolic activity and growth state in the vascular endothelium.
Wilhelm K; Happel K; Eelen G; Schoors S; Oellerich MF; Lim R; Zimmermann B; Aspalter IM; Franco CA; Boettger T; Braun T; Fruttiger M; Rajewsky K; Keller C; Brüning JC; Gerhardt H; Carmeliet P; Potente M
Nature; 2016 Jan; 529(7585):216-20. PubMed ID: 26735015
[TBL] [Abstract][Full Text] [Related]
2. Control of endothelial quiescence by FOXO-regulated metabolites.
Andrade J; Shi C; Costa ASH; Choi J; Kim J; Doddaballapur A; Sugino T; Ong YT; Castro M; Zimmermann B; Kaulich M; Guenther S; Wilhelm K; Kubota Y; Braun T; Koh GY; Grosso AR; Frezza C; Potente M
Nat Cell Biol; 2021 Apr; 23(4):413-423. PubMed ID: 33795871
[TBL] [Abstract][Full Text] [Related]
3. NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation.
Kuosmanen SM; Kansanen E; Kaikkonen MU; Sihvola V; Pulkkinen K; Jyrkkänen HK; Tuoresmäki P; Hartikainen J; Hippeläinen M; Kokki H; Tavi P; Heikkinen S; Levonen AL
Nucleic Acids Res; 2018 Feb; 46(3):1124-1138. PubMed ID: 29161413
[TBL] [Abstract][Full Text] [Related]
4. FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis.
Dharaneeswaran H; Abid MR; Yuan L; Dupuis D; Beeler D; Spokes KC; Janes L; Sciuto T; Kang PM; Jaminet SS; Dvorak A; Grant MA; Regan ER; Aird WC
Circ Res; 2014 Jul; 115(2):238-251. PubMed ID: 24874427
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.
Potente M; Urbich C; Sasaki K; Hofmann WK; Heeschen C; Aicher A; Kollipara R; DePinho RA; Zeiher AM; Dimmeler S
J Clin Invest; 2005 Sep; 115(9):2382-92. PubMed ID: 16100571
[TBL] [Abstract][Full Text] [Related]
6. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.
Riddell M; Nakayama A; Hikita T; Mirzapourshafiyi F; Kawamura T; Pasha A; Li M; Masuzawa M; Looso M; Steinbacher T; Ebnet K; Potente M; Hirose T; Ohno S; Fleming I; Gattenlöhner S; Aung PP; Phung T; Yamasaki O; Yanagi T; Umemura H; Nakayama M
Nat Commun; 2018 Dec; 9(1):5357. PubMed ID: 30559384
[TBL] [Abstract][Full Text] [Related]
7. Endothelial-specific FoxO1 depletion prevents obesity-related disorders by increasing vascular metabolism and growth.
Rudnicki M; Abdifarkosh G; Nwadozi E; Ramos SV; Makki A; Sepa-Kishi DM; Ceddia RB; Perry CG; Roudier E; Haas TL
Elife; 2018 Dec; 7():. PubMed ID: 30511639
[TBL] [Abstract][Full Text] [Related]
8. Flow-dependent regulation of angiopoietin-2.
Goettsch W; Gryczka C; Korff T; Ernst E; Goettsch C; Seebach J; Schnittler HJ; Augustin HG; Morawietz H
J Cell Physiol; 2008 Feb; 214(2):491-503. PubMed ID: 17960565
[TBL] [Abstract][Full Text] [Related]
9. Endothelial FoxO1 is an intrinsic regulator of thrombospondin 1 expression that restrains angiogenesis in ischemic muscle.
Roudier E; Milkiewicz M; Birot O; Slopack D; Montelius A; Gustafsson T; Paik JH; DePinho RA; Casale GP; Pipinos II; Haas TL
Angiogenesis; 2013 Oct; 16(4):759-72. PubMed ID: 23677673
[TBL] [Abstract][Full Text] [Related]
10. AKT/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations.
Si Y; Huang J; Li X; Fu Y; Xu R; Du Y; Cheng J; Jiang H
Cell Commun Signal; 2020 Aug; 18(1):139. PubMed ID: 32867785
[TBL] [Abstract][Full Text] [Related]
11. PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.
Liu S; Lai L; Zuo Q; Dai F; Wu L; Wang Y; Zhou Q; Liu J; Liu J; Li L; Lin Q; Creighton CJ; Costello MG; Huang S; Jia C; Liao L; Luo H; Fu J; Liu M; Yi Z; Xiao J; Li X
J Mol Cell Cardiol; 2014 Jul; 72():28-38. PubMed ID: 24560667
[TBL] [Abstract][Full Text] [Related]
12. FoxO1 regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in human endothelial cells and subjects with atherosclerosis.
Menghini R; Casagrande V; Cardellini M; Ballanti M; Davato F; Cardolini I; Stoehr R; Fabrizi M; Morelli M; Anemona L; Bernges I; Schwedhelm E; Ippoliti A; Mauriello A; Böger RH; Federici M
Atherosclerosis; 2015 Sep; 242(1):230-5. PubMed ID: 26226438
[TBL] [Abstract][Full Text] [Related]
13. Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway.
Cao Y; Kamioka Y; Yokoi N; Kobayashi T; Hino O; Onodera M; Mochizuki N; Nakae J
J Biol Chem; 2006 Dec; 281(52):40242-51. PubMed ID: 17077083
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of CD4 T cell fitness through regulation of Foxo1.
Newton RH; Shrestha S; Sullivan JM; Yates KB; Compeer EB; Ron-Harel N; Blazar BR; Bensinger SJ; Haining WN; Dustin ML; Campbell DJ; Chi H; Turka LA
Nat Immunol; 2018 Aug; 19(8):838-848. PubMed ID: 29988091
[TBL] [Abstract][Full Text] [Related]
15. FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of ROCK1/Drp1-mediated mitochondrial fission.
Shi Y; Fan S; Wang D; Huyan T; Chen J; Chen J; Su J; Li X; Wang Z; Xie S; Yun C; Li X; Tie L
Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2481-2494. PubMed ID: 29654945
[TBL] [Abstract][Full Text] [Related]
16. Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy.
Domigan CK; Warren CM; Antanesian V; Happel K; Ziyad S; Lee S; Krall A; Duan L; Torres-Collado AX; Castellani LW; Elashoff D; Christofk HR; van der Bliek AM; Potente M; Iruela-Arispe ML
J Cell Sci; 2015 Jun; 128(12):2236-48. PubMed ID: 25956888
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC.
Tan P; Guan H; Xie L; Mi B; Fang Z; Li J; Li F
Sci Rep; 2015 Nov; 5():16835. PubMed ID: 26568463
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
19. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
Lu Y; Wu Y; Feng X; Shen R; Wang JH; Fallahi M; Li W; Yang C; Hankey W; Zhao W; Ganju RK; Li MO; Cleveland JL; Zou X
J Clin Invest; 2014 Apr; 124(4):1672-84. PubMed ID: 24614102
[TBL] [Abstract][Full Text] [Related]
20. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
